Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non-toxic'

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):e360-e361. doi: 10.1111/jdv.14935. Epub 2018 Mar 30.

Authors

M Dumas¹, C Hua¹, C Hotz¹, C Velter¹, T A Duong¹, T Maraffi², N Ortonne^{3

4}, S Hüe^{4

5}, L Fardet¹, N de Prost², P Wolkenstein^{1

4

6}, S Ingen-Housz-Oro^{1

6}, O Chosidow^{1

4

6}

Affiliations

¹ Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.
² Intensive Care Unit, AP-HP, Henri Mondor Hospital, Créteil, France.
³ Pathology Department, AP-HP, Henri Mondor Hospital, Créteil, France.
⁴ Université Paris Est Créteil Val de marne, UPEC, Créteil, France.
⁵ Immunology Department, AP-HP, Henri Mondor hospital, Créteil, France.
⁶ Referral Center for Severe Cutaneous Adverse Reactions, Créteil, France.

PMID: 29524279
DOI: 10.1111/jdv.14935

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Antinuclear / analysis
Autoimmune Diseases / immunology*
Cyclophosphamide / administration & dosage
Cyclophosphamide / therapeutic use
Fatal Outcome
Female
Humans
Hydroxychloroquine / administration & dosage
Hydroxychloroquine / therapeutic use
Methylprednisolone / administration & dosage
Methylprednisolone / therapeutic use
Middle Aged
Prednisone / administration & dosage
Prednisone / therapeutic use
Stevens-Johnson Syndrome / drug therapy
Stevens-Johnson Syndrome / etiology*
Stevens-Johnson Syndrome / immunology

Substances

Antibodies, Antinuclear
Hydroxychloroquine
Cyclophosphamide
Prednisone
Methylprednisolone